In a tough economic climate, the time has come for a new business model at the Critical Path Institute, a nonprofit public-private partnership, says Carolyn Compton, who assumed the position of CEO in February, taking over from founder Raymond Woosley.
Born in 2005, the extra-governmental organization, often called C-Path, has emerged as a showcase for FDA’s Critical Path Initiative, aimed at improving efficiency of drug development Also see "A Critical Test for FDA's Critical Path Initiative" - Pink Sheet, 1 February, 2006.